Toggle navigation
Home
Search
Services
Blog
Contact
About
H Pylori/Human Protein Interactions in Gastric Cancer
Ling, Losee Lucy
Oscient Pharmaceuticals Corporation, Waltham, MA, United States
Search 22 grants from Losee Ling
Search grants from Oscient Pharmaceuticals Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Effect of Blood Transfusion Practices on Cerebral and Somatic Oximetry
PI-3 in Bcr/Abl Tyrosine Kinase-Induced Leukemias
Mechanisms Underlying Synapse Formation & Elimination
Biochemistry of Regulated Pre-Mrna Splicing/Drosophila
Mitochondrial Diseases and Neurodegeneration
Recently added grants:
Determinants of human neutrophil fate after phagocytosis
Forward genetic prediction and testing of virulence loci in herpes simplex virus 1
A randomized, double blind, placebo controlled, phase 2 study testing the use of combination multi-allergen food desensitization with dupilumab or omalizumab in multi-food allergic individuals
Therapeutic UV Disinfection System to Prevent Catheter Related Bloodstream Infections (CRBSIs) in Patients with Peripherally Inserted Central Catheters (PICCs)
Schistosoma Mansoni Infection During Pregnancy: Dissecting the Implications to Fetal Immunity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA069983-01A1
Application #
2009445
Study Section
Special Emphasis Panel (ZRG5-MBC-1 (02))
Project Start
1997-05-01
Project End
1997-11-30
Budget Start
1997-05-01
Budget End
1997-11-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Oscient Pharmaceuticals Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Comments
Be the first to comment on this grant